Source: Eur Respir J 2001; 17: 1208-1215



Rating:

Share or cite this content

Citations should be made in the following way:
Wilschanski M., Famini H., Strauss-Liviatan N., Rivlin J., Blau H., Bibi H., Bentur L., Yahav Y., Springer H., Kramer M.R., Klar A., Ilani A., Kerem B., Kerem E.. Nasal potential difference measurements in patients with atypical cystic fibrosis. Eur Respir J 2001; 17: 1208-1215

Member's Comments

No comment yet.

Related content which might interest you: Atypical cystic fibrosis Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-46-6, page=38 Year: 2006 Nasal potential difference of carriers of the W493R ENaC variant with non-cystic fibrosis bronchiectasis Source: Eur Respir J 2016; 47: 322-324 Year: 2016 Relationship between nasal potential difference (NPD) and respiratory function in cystic fibrosis (CF) patients Source: Eur Respir J 2001; 18: Suppl. 33, 125s Year: 2001 Nasal potential difference (NPD) in cystic fibrosis (CF) and non-CF patients with borderline sweat test Source: Eur Respir J 2001; 18: Suppl. 33, 215s Year: 2001 Analysis of relationship between Nasal Potential Difference, genotype and clinical phenotype in patients with cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 341s Year: 2002 Potential difference test is valuable in the diagnosis of cystic fibrosis (CF) Source: Eur Respir J 2004; 24: Suppl. 48, 614s Year: 2004 Late presenting cystic fibrosis Source: Annual Congress 2005 - Cystic fibrosis: no longer just kids‘ stuff Year: 2005 Genotype/phenotype correlation of the G85E mutation in a large cohort of cystic fibrosis patients Source: Eur Respir J 2004; 23: 679-684 Year: 2004 High morbidity and mortality in cystic fibrosis patients compound heterozygous for 3905insT and ΔF508 Source: Eur Respir J 2001; 17: 1181-1186 Year: 2001 A borderline, or negative sweat test, leads to a diagnostic delay in hypertrypsinaemic cystic fibrosis (CF) infants with mild CFTR mutations Source: Eur Respir J 2001; 18: Suppl. 33, 124s Year: 2001 Aetiology of non cystic fibrosis bronchiectasis and its correlation with the site of pulmonary damage Source: Eur Respir J 2003; 22: Suppl. 45, 504s Year: 2003 Possible mechanisms of action of azithromycin in cystic fibrosis Source: Annual Congress 2005 - Cystic fibrosis lung disease: pieces of the puzzle Year: 2005 The impact of genotype on clinical course of cystic fibrosis (CF) in adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013 Hyperinflation in adult cystic fibrosis (CF) patients: Clinical and functional correlates Source: Annual Congress 2010 - Cystic fibrosis: clinical and laboratory studies Year: 2010 Intestinal current measurement (ICM) as a diagnostic tool for atypical cystic fibrosis Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 The treatment burden of cystic fibrosis: a day-to-day experience with treatment as someone with cystic fibrosis Source: Breathe, 17 (1) 210013; 10.1183/20734735.0013-2021 Year: 2021 The clinical significance of oropharyngeal cultures in young children with cystic fibrosis Source: Eur Respir J, 51 (5) 1800238; 10.1183/13993003.00238-2018 Year: 2018 Does this patient have cystic fibrosis?  Source: International Congress 2017 – GR6 Paediatric Ground Round: an interactive session Year: 2017 Comparison of functional capacity, muscle strength, body composition in patients with cystic fibrosis, non-cystic bronchiectasis and healthy controls Source: Annual Congress 2012 - Assessment of physical activity, exercise, muscle function and clinical characteristics as outcomes in physiotherapy and rehabilitation Year: 2012 Single-breath washout and association with structural lung changes in children with cystic fibrosis Source: International Congress 2016 – Advanced lung function testing in childhood respiratory and sleep disease Year: 2016